ID   CP11A_HUMAN             Reviewed;         521 AA.
AC   P05108; A8K8D5; B3KPU8; G3XAD7; Q15081; Q16805; Q8N1A7;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   10-MAY-2017, entry version 191.
DE   RecName: Full=Cholesterol side-chain cleavage enzyme, mitochondrial;
DE            EC=1.14.15.6;
DE   AltName: Full=CYPXIA1;
DE   AltName: Full=Cholesterol desmolase;
DE   AltName: Full=Cytochrome P450 11A1;
DE   AltName: Full=Cytochrome P450(scc);
DE   Flags: Precursor;
GN   Name=CYP11A1; Synonyms=CYP11A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3024157; DOI=10.1073/pnas.83.23.8962;
RA   Chung B.-C., Matteson K.J., Voutilainen R., Mohandas T.K.,
RA   Miller W.L.;
RT   "Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning,
RT   assignment of the gene to chromosome 15, and expression in the
RT   placenta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:8962-8966(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=3038854; DOI=10.1093/oxfordjournals.jbchem.a121955;
RA   Morohashi K., Sogawa K., Omura T., Fujii-Kuriyama Y.;
RT   "Gene structure of human cytochrome P-450(SCC), cholesterol
RT   desmolase.";
RL   J. Biochem. 101:879-887(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-89.
RA   Chung B.-C.;
RL   Submitted (JAN-1989) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PROTEIN SEQUENCE OF 51-54, AND INDUCTION.
RC   TISSUE=Choriocarcinoma;
RX   PubMed=1849407; DOI=10.1042/bj2740813;
RA   Hu M.C., Guo I.C., Lin J.H., Chung B.-C.;
RT   "Regulated expression of cytochrome P-450scc (cholesterol-side-chain
RT   cleavage enzyme) in cultured cell lines detected by antibody against
RT   bacterially expressed human protein.";
RL   Biochem. J. 274:813-817(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 283-521 (ISOFORM 1).
RX   PubMed=2419119; DOI=10.1210/endo-118-4-1296;
RA   Matteson K.J., Chung B.-C., Urdea M.S., Miller W.L.;
RT   "Study of cholesterol side-chain cleavage (20,22 desmolase) deficiency
RT   causing congenital lipoid adrenal hyperplasia using bovine-sequence
RT   P450scc oligodeoxyribonucleotide probes.";
RL   Endocrinology 118:1296-1305(1986).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 41-521 IN COMPLEXES WITH
RP   FDX1; HEME AND CHOLESTEROL, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   PATHWAY, AND INTERACTION WITH FDX1.
RX   PubMed=21636783; DOI=10.1073/pnas.1019441108;
RA   Strushkevich N., MacKenzie F., Cherkesova T., Grabovec I., Usanov S.,
RA   Park H.W.;
RT   "Structural basis for pregnenolone biosynthesis by the mitochondrial
RT   monooxygenase system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:10139-10143(2011).
RN   [11]
RP   VARIANT LYS-314.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [12]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [13]
RP   VARIANT AICSR GLY-ASP-271 INS.
RX   PubMed=11502818; DOI=10.1210/jcem.86.8.7748;
RA   Tajima T., Fujieda K., Kouda N., Nakae J., Miller W.L.;
RT   "Heterozygous mutation in the cholesterol side chain cleavage enzyme
RT   (P450scc) gene in a patient with 46,XY sex reversal and adrenal
RT   insufficiency.";
RL   J. Clin. Endocrinol. Metab. 86:3820-3825(2001).
RN   [14]
RP   VARIANTS AICSR VAL-189 AND TRP-353.
RX   PubMed=12161514; DOI=10.1210/jcem.87.8.8763;
RA   Katsumata N., Ohtake M., Hojo T., Ogawa E., Hara T., Sato N.,
RA   Tanaka T.;
RT   "Compound heterozygous mutations in the cholesterol side-chain
RT   cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency
RT   in humans.";
RL   J. Clin. Endocrinol. Metab. 87:3808-3813(2002).
RN   [15]
RP   VARIANT AICSR VAL-359, AND CHARACTERIZATION OF VARIANT AICSR VAL-359.
RX   PubMed=16705068; DOI=10.1210/jc.2005-2230;
RA   al Kandari H., Katsumata N., Alexander S., Rasoul M.A.;
RT   "Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1)
RT   in 46, XY patient with adrenal insufficiency, complete sex reversal,
RT   and agenesis of corpus callosum.";
RL   J. Clin. Endocrinol. Metab. 91:2821-2826(2006).
RN   [16]
RP   VARIANTS AICSR TRP-141 AND GLU-415, AND CHARACTERIZATION OF VARIANTS
RP   AICSR TRP-141 AND GLU-415.
RX   PubMed=18182448; DOI=10.1210/jc.2007-2330;
RA   Kim C.J., Lin L., Huang N., Quigley C.A., Avruskin T.W.,
RA   Achermann J.C., Miller W.L.;
RT   "Severe combined adrenal and gonadal deficiency caused by novel
RT   mutations in the cholesterol side chain cleavage enzyme, P450scc.";
RL   J. Clin. Endocrinol. Metab. 93:696-702(2008).
RN   [17]
RP   VARIANT AICSR PRO-222, AND CHARACTERIZATION OF VARIANT AICSR PRO-222.
RX   PubMed=19116240; DOI=10.1210/jc.2008-1118;
RA   Rubtsov P., Karmanov M., Sverdlova P., Spirin P., Tiulpakov A.;
RT   "A novel homozygous mutation in CYP11A1 gene is associated with late-
RT   onset adrenal insufficiency and hypospadias in a 46,XY patient.";
RL   J. Clin. Endocrinol. Metab. 94:936-939(2009).
CC   -!- FUNCTION: Catalyzes the side-chain cleavage reaction of
CC       cholesterol to pregnenolone. {ECO:0000269|PubMed:21636783}.
CC   -!- CATALYTIC ACTIVITY: Cholesterol + 6 reduced adrenodoxin + 3 O(2) +
CC       6 H(+) = pregnenolone + 4-methylpentanal + 6 oxidized adrenodoxin
CC       + 4 H(2)O. {ECO:0000269|PubMed:21636783}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:21636783};
CC   -!- PATHWAY: Lipid metabolism; C21-steroid hormone metabolism.
CC       {ECO:0000269|PubMed:21636783}.
CC   -!- SUBUNIT: Interacts with FDX1/adrenodoxin.
CC       {ECO:0000269|PubMed:21636783}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05108-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05108-2; Sequence=VSP_045695;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: By 8-bromo cyclic AMP. {ECO:0000269|PubMed:1849407}.
CC   -!- DISEASE: Adrenal insufficiency, congenital, with 46,XY sex
CC       reversal (AICSR) [MIM:613743]: A rare disorder that can present as
CC       acute adrenal insufficiency in infancy or childhood. ACTH and
CC       plasma renin activity are elevated and adrenal steroids are
CC       inappropriately low or absent; the 46,XY patients have female
CC       external genitalia, sometimes with clitoromegaly. The phenotypic
CC       spectrum ranges from prematurity, complete underandrogenization,
CC       and severe early-onset adrenal failure to term birth with
CC       clitoromegaly and later-onset adrenal failure. Patients with
CC       congenital adrenal insufficiency do not manifest the massive
CC       adrenal enlargement typical of congenital lipoid adrenal
CC       hyperplasia. {ECO:0000269|PubMed:11502818,
CC       ECO:0000269|PubMed:12161514, ECO:0000269|PubMed:16705068,
CC       ECO:0000269|PubMed:18182448, ECO:0000269|PubMed:19116240}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14565; AAA52162.1; -; mRNA.
DR   EMBL; X05367; CAA28965.1; -; Genomic_DNA.
DR   EMBL; X05368; CAA28965.1; JOINED; Genomic_DNA.
DR   EMBL; X05369; CAA28965.1; JOINED; Genomic_DNA.
DR   EMBL; X05370; CAA28965.1; JOINED; Genomic_DNA.
DR   EMBL; X05371; CAA28965.1; JOINED; Genomic_DNA.
DR   EMBL; X05372; CAA28965.1; JOINED; Genomic_DNA.
DR   EMBL; X05373; CAA28965.1; JOINED; Genomic_DNA.
DR   EMBL; X05374; CAA28965.1; JOINED; Genomic_DNA.
DR   EMBL; AK056794; BAG51810.1; -; mRNA.
DR   EMBL; AK292300; BAF84989.1; -; mRNA.
DR   EMBL; AC090826; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471136; EAW99341.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99342.1; -; Genomic_DNA.
DR   EMBL; BC032329; AAH32329.1; -; mRNA.
DR   EMBL; X14257; CAA32471.1; -; Genomic_DNA.
DR   EMBL; M28253; AAA36404.1; -; mRNA.
DR   CCDS; CCDS32291.1; -. [P05108-1]
DR   CCDS; CCDS45303.1; -. [P05108-2]
DR   PIR; A25922; A25922.
DR   RefSeq; NP_000772.2; NM_000781.2. [P05108-1]
DR   RefSeq; NP_001093243.1; NM_001099773.1. [P05108-2]
DR   UniGene; Hs.303980; -.
DR   PDB; 3N9Y; X-ray; 2.10 A; A/B=41-521.
DR   PDB; 3N9Z; X-ray; 2.17 A; A/B=41-521.
DR   PDB; 3NA0; X-ray; 2.50 A; A/B=44-514.
DR   PDB; 3NA1; X-ray; 2.25 A; A/B=41-521.
DR   PDBsum; 3N9Y; -.
DR   PDBsum; 3N9Z; -.
DR   PDBsum; 3NA0; -.
DR   PDBsum; 3NA1; -.
DR   ProteinModelPortal; P05108; -.
DR   SMR; P05108; -.
DR   BioGrid; 107955; 5.
DR   IntAct; P05108; 4.
DR   MINT; MINT-1200919; -.
DR   STRING; 9606.ENSP00000268053; -.
DR   BindingDB; P05108; -.
DR   ChEMBL; CHEMBL2033; -.
DR   DrugBank; DB00357; Aminoglutethimide.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB00882; Clomifene.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB01396; Digitoxin.
DR   DrugBank; DB00390; Digoxin.
DR   DrugBank; DB02901; Dihydrotestosterone.
DR   DrugBank; DB00917; Dinoprostone.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB00857; Terbinafine.
DR   DrugBank; DB00624; Testosterone.
DR   SwissLipids; SLP:000001196; -.
DR   iPTMnet; P05108; -.
DR   PhosphoSitePlus; P05108; -.
DR   BioMuta; CYP11A1; -.
DR   DMDM; 143811381; -.
DR   EPD; P05108; -.
DR   PaxDb; P05108; -.
DR   PeptideAtlas; P05108; -.
DR   PRIDE; P05108; -.
DR   DNASU; 1583; -.
DR   Ensembl; ENST00000268053; ENSP00000268053; ENSG00000140459. [P05108-1]
DR   Ensembl; ENST00000358632; ENSP00000351455; ENSG00000140459. [P05108-2]
DR   GeneID; 1583; -.
DR   KEGG; hsa:1583; -.
DR   UCSC; uc002axs.3; human. [P05108-1]
DR   CTD; 1583; -.
DR   DisGeNET; 1583; -.
DR   GeneCards; CYP11A1; -.
DR   HGNC; HGNC:2590; CYP11A1.
DR   HPA; HPA016436; -.
DR   MalaCards; CYP11A1; -.
DR   MIM; 118485; gene.
DR   MIM; 613743; phenotype.
DR   neXtProt; NX_P05108; -.
DR   OpenTargets; ENSG00000140459; -.
DR   Orphanet; 168558; 46,XY disorder of sex development - adrenal insufficiency due to CYP11A1 deficiency.
DR   Orphanet; 289548; Inherited isolated adrenal insufficiency due to CYP11A1 deficiency.
DR   PharmGKB; PA27089; -.
DR   eggNOG; KOG0159; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000119243; -.
DR   HOGENOM; HOG000013161; -.
DR   HOVERGEN; HBG051098; -.
DR   InParanoid; P05108; -.
DR   KO; K00498; -.
DR   OMA; KDHVAAW; -.
DR   OrthoDB; EOG091G04MV; -.
DR   PhylomeDB; P05108; -.
DR   TreeFam; TF105094; -.
DR   BioCyc; MetaCyc:HS06719-MONOMER; -.
DR   BRENDA; 1.14.15.6; 2681.
DR   Reactome; R-HSA-196108; Pregnenolone biosynthesis.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   Reactome; R-HSA-5579026; Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR).
DR   SABIO-RK; P05108; -.
DR   UniPathway; UPA00229; -.
DR   ChiTaRS; CYP11A1; human.
DR   EvolutionaryTrace; P05108; -.
DR   GeneWiki; Cholesterol_side-chain_cleavage_enzyme; -.
DR   GenomeRNAi; 1583; -.
DR   PRO; PR:P05108; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140459; -.
DR   CleanEx; HS_CYP11A1; -.
DR   ExpressionAtlas; P05108; baseline and differential.
DR   Genevisible; P05108; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0008386; F:cholesterol monooxygenase (side-chain-cleaving) activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0006700; P:C21-steroid hormone biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0008203; P:cholesterol metabolic process; IDA:UniProtKB.
DR   GO; GO:0016125; P:sterol metabolic process; TAS:Reactome.
DR   GO; GO:0042359; P:vitamin D metabolic process; ISS:UniProtKB.
DR   InterPro; IPR033283; CYP11A1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   PANTHER; PTHR24279:SF93; PTHR24279:SF93; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol metabolism;
KW   Complete proteome; Direct protein sequencing; Disease mutation; Heme;
KW   Iron; Lipid metabolism; Membrane; Metal-binding; Mitochondrion;
KW   Monooxygenase; Oxidoreductase; Polymorphism; Reference proteome;
KW   Steroid metabolism; Steroidogenesis; Sterol metabolism;
KW   Transit peptide.
FT   TRANSIT       1     39       Mitochondrion.
FT   CHAIN        40    521       Cholesterol side-chain cleavage enzyme,
FT                                mitochondrial.
FT                                /FTId=PRO_0000003585.
FT   METAL       462    462       Iron (heme axial ligand).
FT   VAR_SEQ       1    158       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045695.
FT   VARIANT     141    141       L -> W (in AICSR; reduced activity;
FT                                dbSNP:rs121912813).
FT                                {ECO:0000269|PubMed:18182448}.
FT                                /FTId=VAR_065241.
FT   VARIANT     189    189       A -> V (in AICSR; no loss of activity;
FT                                dbSNP:rs121912811).
FT                                {ECO:0000269|PubMed:12161514}.
FT                                /FTId=VAR_016949.
FT   VARIANT     222    222       L -> P (in AICSR; markedly reduced
FT                                activity; dbSNP:rs387906601).
FT                                {ECO:0000269|PubMed:19116240}.
FT                                /FTId=VAR_065242.
FT   VARIANT     271    271       D -> DGD (in AICSR; complete loss of
FT                                activity). {ECO:0000269|PubMed:11502818}.
FT                                /FTId=VAR_016950.
FT   VARIANT     314    314       E -> K (in dbSNP:rs6161).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_013944.
FT   VARIANT     353    353       R -> W (in AICSR; loss of activity;
FT                                dbSNP:rs72547508).
FT                                {ECO:0000269|PubMed:12161514}.
FT                                /FTId=VAR_016951.
FT   VARIANT     359    359       A -> V (in AICSR; markedly reduced
FT                                activity; dbSNP:rs121912812).
FT                                {ECO:0000269|PubMed:16705068}.
FT                                /FTId=VAR_065243.
FT   VARIANT     415    415       V -> E (in AICSR; complete loss of
FT                                activity; dbSNP:rs121912814).
FT                                {ECO:0000269|PubMed:18182448}.
FT                                /FTId=VAR_065244.
FT   CONFLICT     16     16       C -> Y (in Ref. 1; AAA52162).
FT                                {ECO:0000305}.
FT   CONFLICT    274    274       F -> L (in Ref. 2; CAA28965).
FT                                {ECO:0000305}.
FT   CONFLICT    283    283       N -> H (in Ref. 9; AAA36404).
FT                                {ECO:0000305}.
FT   CONFLICT    301    301       I -> M (in Ref. 1; AAA52162 and 9;
FT                                AAA36404). {ECO:0000305}.
FT   CONFLICT    505    505       K -> E (in Ref. 3; BAG51810).
FT                                {ECO:0000305}.
FT   HELIX        48     50       {ECO:0000244|PDB:3N9Y}.
FT   HELIX        58     68       {ECO:0000244|PDB:3N9Y}.
FT   HELIX        71     73       {ECO:0000244|PDB:3N9Y}.
FT   HELIX        74     85       {ECO:0000244|PDB:3N9Y}.
FT   STRAND       87     93       {ECO:0000244|PDB:3N9Y}.
FT   STRAND       96    101       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       104    112       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       124    132       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       139    141       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       144    158       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       161    164       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       167    189       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      190    196       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       199    215       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      223    225       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       228    244       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       245    247       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       252    258       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       260    291       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       301    307       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       313    328       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       330    344       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       346    362       {ECO:0000244|PDB:3N9Y}.
FT   TURN        363    365       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       367    370       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       375    387       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      390    397       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      402    404       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      407    409       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      414    418       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       419    423       {ECO:0000244|PDB:3N9Y}.
FT   TURN        426    428       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      429    431       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       437    440       {ECO:0000244|PDB:3N9Y}.
FT   TURN        449    451       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       458    460       {ECO:0000244|PDB:3N9Y}.
FT   HELIX       465    482       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      483    486       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      495    505       {ECO:0000244|PDB:3N9Y}.
FT   STRAND      509    513       {ECO:0000244|PDB:3N9Y}.
SQ   SEQUENCE   521 AA;  60102 MW;  AB0501E7A5665D8B CRC64;
     MLAKGLPPRS VLVKGCQTFL SAPREGLGRL RVPTGEGAGI STRSPRPFNE IPSPGDNGWL
     NLYHFWRETG THKVHLHHVQ NFQKYGPIYR EKLGNVESVY VIDPEDVALL FKSEGPNPER
     FLIPPWVAYH QYYQRPIGVL LKKSAAWKKD RVALNQEVMA PEATKNFLPL LDAVSRDFVS
     VLHRRIKKAG SGNYSGDISD DLFRFAFESI TNVIFGERQG MLEEVVNPEA QRFIDAIYQM
     FHTSVPMLNL PPDLFRLFRT KTWKDHVAAW DVIFSKADIY TQNFYWELRQ KGSVHHDYRG
     ILYRLLGDSK MSFEDIKANV TEMLAGGVDT TSMTLQWHLY EMARNLKVQD MLRAEVLAAR
     HQAQGDMATM LQLVPLLKAS IKETLRLHPI SVTLQRYLVN DLVLRDYMIP AKTLVQVAIY
     ALGREPTFFF DPENFDPTRW LSKDKNITYF RNLGFGWGVR QCLGRRIAEL EMTIFLINML
     ENFRVEIQHL SDVGTTFNLI LMPEKPISFT FWPFNQEATQ Q
//
